Hvsen Biotechnology Co., Ltd. (300871.SZ)
CNY 22.1
(-8.3%)
CNY 22.1
(-8.3%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.01 Billion CNY | -0.31% |
| 2022 | 1.02 Billion CNY | 2.68% |
| 2021 | 996.21 Million CNY | 28.14% |
| 2020 | 777.45 Million CNY | 81.98% |
| 2019 | 427.21 Million CNY | 1.27% |
| 2018 | 421.87 Million CNY | 5.54% |
| 2017 | 399.71 Million CNY | 55.06% |
| 2016 | 257.78 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 204.5 Million CNY | -37.72% |
| 2024 Q3 | 353.55 Million CNY | 56.83% |
| 2024 Q2 | 227.16 Million CNY | 11.08% |
| 2023 Q1 | 230.41 Million CNY | -34.43% |
| 2023 FY | 1.01 Billion CNY | -0.31% |
| 2023 Q4 | 328.37 Million CNY | 35.52% |
| 2023 Q3 | 242.3 Million CNY | 10.81% |
| 2023 Q2 | 218.67 Million CNY | -5.1% |
| 2022 Q2 | 191.35 Million CNY | -6.96% |
| 2022 FY | 1.02 Billion CNY | 2.68% |
| 2022 Q1 | 205.66 Million CNY | -17.83% |
| 2022 Q3 | 274.46 Million CNY | 43.43% |
| 2022 Q4 | 351.42 Million CNY | 28.04% |
| 2021 Q4 | 250.3 Million CNY | 19.1% |
| 2021 FY | 996.21 Million CNY | 28.14% |
| 2021 Q3 | 210.17 Million CNY | -5.43% |
| 2021 Q1 | 313.49 Million CNY | 11.53% |
| 2021 Q2 | 222.23 Million CNY | -29.11% |
| 2020 FY | 777.45 Million CNY | 81.98% |
| 2020 Q4 | 281.08 Million CNY | 34.13% |
| 2020 Q3 | 209.55 Million CNY | 38.03% |
| 2020 Q2 | 151.82 Million CNY | 12.46% |
| 2020 Q1 | 135 Million CNY | -15.02% |
| 2019 Q3 | 86.96 Million CNY | 0.0% |
| 2019 Q4 | 158.86 Million CNY | 82.69% |
| 2019 FY | 427.21 Million CNY | 1.27% |
| 2018 FY | 421.87 Million CNY | 5.54% |
| 2017 FY | 399.71 Million CNY | 55.06% |
| 2016 FY | 257.78 Million CNY | 0.0% |